₩ 1037000
Key Takeaways
Risk factor
Low price volatility
Profitability factor
Strong margins and returns
About
Samsung Biologics Co.,Ltd. engages in the contract manufacturing organization (CMO) business for biopharmaceuticals products. The company operates in two segments, CMO and Contract Development Organization (CDO). It is involved in the provision of CDO services, including cell line development, upstream and downstream processes, and analytical methods and formulations. The company also offers aseptic filling, lyophilization,...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA
Target Price
The average target price of 207940.KS is 1375142 and suggests 32% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation t
